These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1267443)

  • 1. Comparison of phlebitis produced by cephapirin and cephalothin.
    Cross AS; Tramont EC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):722-4. PubMed ID: 1267443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phlebitis associated with the intravenous use of cephalothin and cephapirin.
    Sorrentino AP; Haughey EJ; Cronin DW; Bohen LN
    Am J Hosp Pharm; 1976 Jul; 33(7):642-4. PubMed ID: 941915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.
    Berger S; Ernst EC; Barza M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):575-9. PubMed ID: 5053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.
    Lane AZ; Taggart JG; Iles RL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):234-5. PubMed ID: 4790563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin.
    Carrizosa J; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Feb; 3(2):306-7. PubMed ID: 4597719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of side effects of intravenous cephapirin and cephalothin with special reference to the incidence of phlebitis].
    Watanabe A; Oizumi K; Konno K
    Jpn J Antibiot; 1983 Dec; 36(12):3395-8. PubMed ID: 6674550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
    Inagaki J; Bodey GP
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):37-43. PubMed ID: 4632504
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind comparison of phlebitis produced by cefazolin versus cephalothin.
    Shemonsky NK; Carrizosa JC; Kaye D; Levison ME
    Antimicrob Agents Chemother; 1975 Apr; 7(4):481-2. PubMed ID: 1147583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thrombophlebitis associated with three cephalosporin antibiotics.
    Siebert WT; Westerman EL; Smilack JD; Bradshaw MW; Williams TW
    Antimicrob Agents Chemother; 1976 Sep; 10(3):467-9. PubMed ID: 791101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of phlebitis associated with cefazolin and cephalothin.
    Cole DR
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):75-7. PubMed ID: 789268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics.
    Meguro S; Kuraishi Y; Kobayashi T; Chinen T; Ikeda K; Nagata T; Ichiba K; Abe M
    Jpn J Antibiot; 1980 Nov; 33(11):1163-5. PubMed ID: 7241794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of phlebitis produced by cephalothin infusions with buffered and unbuffered diluents.
    Carrizosa J; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1974 Feb; 5(2):192-3. PubMed ID: 4840431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1976 Apr; 9(4):646-8. PubMed ID: 1267438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of buffering on the incidence and severity of cephalothin-induced phlebitis.
    Lipman AG
    Am J Hosp Pharm; 1974 Mar; 31(3):266-8. PubMed ID: 4819440
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses.
    Sanders WE; Johnson JE; Taggart JG
    N Engl J Med; 1974 Feb; 290(8):424-9. PubMed ID: 4811017
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cephalothin-induced phlebitis.
    Welk PC; Campbell A
    Am J Hosp Pharm; 1977 Jun; 34(6):562, 564, 570. PubMed ID: 879173
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoprophylaxis in cardiac and orthopedic surgery: comparison of cephalothin and cephapirin.
    Bryant RE; Hartstein AI; Starr A; Beals RK
    South Med J; 1982 Sep; 75(9):1057-62. PubMed ID: 7123323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of cephapirin, cephalothin, and methicillin in cardiovascular surgery.
    Effler DB; Gensini GG; Giambartolomei AA
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):313-6. PubMed ID: 7107083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.